PerkinElmer Inc.
940 Winter Street
Waltham,
MA 02451
United States - Map
Phone: 781-663-6900
Fax: 781-663-5985
Web Site: http://www.perkinelmer.com
| PerkinElmer, Inc., a technology company, focuses on improving the health and safety of people and their environment through scientific solutions and components. It provides scientific instruments, consumables, and services to the pharmaceutical, biomedical, environmental testing, and general industrial markets. The companys Human Health business develops research and diagnostic instrumentation technologies, as well as clinical resources and support services to fight illness, provide medical insight, and develop therapies. PerkinElmer has the portfolios of functional cellular science research technologies, as well as GPCR and kinase products used in researching approximately 75% of drug pathways. It also engages in pre-natal and newborn screening; and umbilical cord blood storage. This business focuses on cellular research; clinical genetics and diagnostics; custom services; drug discovery; life science research; medical imaging technologies; and pharmaceutical development and manufacturing areas. PerkinElmers Environmental Health business develops analytical instrumentation, illumination and detection technologies, and support services to improve the quality and sustainability of the environment; the integrity and safety of everything that can be touched and consumed; and the security of the surroundings. Its environmental monitoring, consumer safety solutions, and renewable energy testing technologies focuses on a cleaner, safer planet. PerkinElmers Environmental Health business focuses on consumer product safety; environmental analysis; food, flavors, and agriculture analysis; forensic analysis; laboratory services; and illumination and detection technologies renewable energy areas. PerkinElmer was founded in 1931 and is headquartered in Waltham, Massachusetts. |
|
| Key Statistics |
| |
| | Pay | Exercised | Mr. Robert Friel , 53
Chairman, Chief Exec. Officer, Pres, Member of Exec. Committee and Member of Fin. Committee |
$
3.61M |
$
0 | Mr. John A. Roush , 43
Sr. VP and Pres of Environmental Health |
$
1.31M |
$
766.00K | Dr. Daniel R. Marshak Ph.D., 51
Chief Scientific Officer, Sr. VP and Pres of Greater China Operations |
$
685.00K |
$
0 | Mr. Richard F. Walsh , 56
Chief Administrator Officer and Sr. VP |
$
1.17M |
$
0 | Mr. Michael L. Battles , 41
VP, Controller and Chief Financial Officer of Human Health |
$
527.00K |
$
0 |
|
|
|
Dollar amounts are as of
31-Dec-08
and compensation values are for the last fiscal
year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of
options exercised during the fiscal year.
| |
|
0.08% Nasdaq 
0.11 (0.57%) 
Profile
